These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19470736)

  • 21. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
    Ando T; Nishimura M; Oka Y
    Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting DNA methylation.
    Issa JP; Kantarjian HM
    Clin Cancer Res; 2009 Jun; 15(12):3938-46. PubMed ID: 19509174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decitabine and its role in the treatment of hematopoietic malignancies.
    Plimack ER; Kantarjian HM; Issa JP
    Leuk Lymphoma; 2007 Aug; 48(8):1472-81. PubMed ID: 17701577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
    Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
    Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
    Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
    Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
    Hagemann S; Heil O; Lyko F; Brueckner B
    PLoS One; 2011 Mar; 6(3):e17388. PubMed ID: 21408221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway.
    Lavelle D; DeSimone J; Hankewych M; Kousnetzova T; Chen YH
    Leuk Res; 2003 Nov; 27(11):999-1007. PubMed ID: 12859993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
    Stresemann C; Lyko F
    Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.
    Chuang JC; Warner SL; Vollmer D; Vankayalapati H; Redkar S; Bearss DJ; Qiu X; Yoo CB; Jones PA
    Mol Cancer Ther; 2010 May; 9(5):1443-50. PubMed ID: 20442312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
    Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
    Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decitabine--bedside to bench.
    Oki Y; Aoki E; Issa JP
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):140-52. PubMed ID: 17023173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation and gene silencing in cancer.
    Baylin SB
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation in haematological malignancies: the role of decitabine.
    Hennessy BT; Garcia-Manero G; Kantarjian HM; Giles FJ
    Expert Opin Investig Drugs; 2003 Dec; 12(12):1985-93. PubMed ID: 14640942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation-dependent silencing of tumor-selective apoptosis-inducing TRAIL by DNA hypermethylation is antagonized by decitabine.
    Lund P; Kotova I; Kedinger V; Khanwalkar H; Voltz E; Hahn WC; Gronemeyer H
    Mol Cancer Ther; 2011 Sep; 10(9):1611-23. PubMed ID: 21697397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decitabine.
    Daskalakis M; Blagitko-Dorfs N; Hackanson B
    Recent Results Cancer Res; 2010; 184():131-57. PubMed ID: 20072836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.
    Fang F; Balch C; Schilder J; Breen T; Zhang S; Shen C; Li L; Kulesavage C; Snyder AJ; Nephew KP; Matei DE
    Cancer; 2010 Sep; 116(17):4043-53. PubMed ID: 20564122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
    Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
    J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of dna methylation by 5-aza-2'-deoxycytidine correlates with induction of K562 cells differentiation.
    Fabianowska-Majewska K; Wyczechowska D; Czyz M
    Adv Exp Med Biol; 2000; 486():343-7. PubMed ID: 11783512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.